Results 11 to 20 of about 61,036 (213)

Model-Informed Precision Dosing of Imipenem in an Obese Adolescent Patient with Augmented Renal Clearance and History of Schizophrenia [PDF]

open access: yesInfection and Drug Resistance
Yueliang Chen,1,* Yun Han,2,3,* Feng Guo,1 Zhenwei Yu2,3 1Intensive Care Unit, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Pharmacy, Sir Run Run Shaw Hospital,
Chen Y, Han Y, Guo F, Yu Z
doaj   +1 more source

Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa [PDF]

open access: yes, 2023
Purpose: Relebactam is a novel β-lactamase inhibitor, which, when combined with imipenem/cilastatin, is active against both class A and class C β-lactamases.
Delgado Valverde, María Mercedes   +6 more
core   +1 more source

RESTORE-IMI 1: A Multicenter, Randomized, Doubleblind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections [PDF]

open access: yes, 2020
Background. The β-lactamase inhibitor relebactam can restore imipenem activity against imipenem-nonsusceptible gram-negative pathogens. We evaluated imipenem/relebactam for treating imipenem-nonsusceptible infections. Methods.
Du, Jiejun   +17 more
core   +1 more source

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates [PDF]

open access: yes, 2021
The current study was aimed at investigating the prevalence of the mutations upstream of the oprD coding region and its promoters among imipenem-resistant and sensitive Pseudomonas aeruginosa isolated from educational hospitals in Yazd City, Iran.
Astani, A.   +8 more
core   +1 more source

Imipenem/relebactam érzékenységi vizsgálat E-teszttel karbapenem rezisztens Pseudomonas aeruginosa által okozott fertőzésekben [PDF]

open access: yes, 2022
A multirezisztens baktériumok (MRK) megjelenése és elterjedése, valamint az infekciók szempontjából magas kockázatú betegek számának emelkedése világszerte egyre nagyobb problémát okoz az egészségügyben. Az utóbbi években felbukkantak a karbapenemekre (
Ráti, Szabina
core  

Effect of sub MIC for Imipenem, Amikacin and Cefixime on Growth and Swarming of Proteus mirabilis [PDF]

open access: yes, 2018
The purpose of the present study is to evaluate the effect sub minimum inhibitory concentration (MIC) of imipenem, amikacin and cefixime on growth and swarming of Proteus mirabilis.
Naeem Rahman aljeburi   +6 more
core   +1 more source

Free Energy Decomposition of CarO Outer Membrane Protein of Acinetobacter baumannii

open access: yesCumhuriyet Science Journal, 2022
The increase in the number of antibiotic-resistant microorganisms reported today has made this issue one of the main topics of all institutes. Acineteobacter baumanni is a species that is on the list of the WHO and plays an important role, especially in ...
Emrah Sarıyer
doaj   +1 more source

The Effects of Colistin on Imipenem MICs in OXA-48 Producing Klebsiella pneumoniae Isolates: An In Vitro Study

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2021
Introduction: A new approach to carbapenem resistance-K. pneumoniae infections is to use combination drug therapies. However, little data are available about the effectiveness of the in vitro carbapenem plus colistin combination against oxacillinase-48 ...
Yücel DUMAN   +3 more
doaj   +1 more source

In-vitro activities of imipenem–colistin, imipenem–tigecycline, and tigecycline–colistin combinations against carbapenem-resistant Enterobacteriaceae* [PDF]

open access: yes, 2018
© 2018, © 2018 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.The aim of the study is to determine in-vitro effects of imipenem–tigecycline, imipenem–colistin and tigecycline–colistin against carbapenem-resistant Enterobacteriaceae (CRE ...
DÜNDAR, DEVRİM   +5 more
core   +1 more source

In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2021
Objective. To evaluate in vitro activity of biapenem and other clinically available carbapenems against Russian clinical isolates of Enterobacterales, Pseudomonas aeruginosa и Acinetobacter spp., including isolates with acquired fermentative mechanisms ...
Kozlov R.S.   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy